Amyris Hosts Event to Preview Launch of Biossance(TM) Brand

EMERYVILLE, Calif., May 1, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it hosted a special event on April 30, 2015, at its headquarters, previewing the upcoming launch of its new consumer brand – Biossance. The premiere product, Biossance™ The Revitalizer features the company's Neossance® squalane, an advanced emollient produced by Amyris that replenishes moisture in the skin by using a moisturizer already present naturally in the human body. Biossance products will initially be distributed and available through online sales via the company's branded Biossance website starting end of May 2015.

During the event, John Melo, President & CEO of Amyris, showcased the exceptional performance of the Biossance product's patented, plant-derived emollient, which locks in essential moisture, as well as the results of home use tests in which consumers agreed that their skin felt instantly hydrated and revitalized and appeared softer and smoother. Melo also highlighted how this exciting new product marks the company's first direct entry into the skin care market − initially with this single product to be launched more broadly in late May 2015 and with an expanded line of several new products expected to follow in late 2015.

"We're very pleased with our consumer test results where 92% of early users liked the product after trial and over 70% of consumers thought the product was unique and liked it better than the products they typically buy in this category," said John Melo, President & CEO. "We're also encouraged by the strong initial consumer response to the product and excited about the follow-on introduction of our additional skin care products later this year."

Find us on Facebook at www.facebook.com/biossance and follow us on Twitter at www.twitter.com/biossance.

About Amyris

Amyris is a global renewable products company providing sustainable alternatives to a variety of non-renewable resources. Amyris uses its innovative bioscience technology to convert plant sugars into hydrocarbon molecules. Amyris creates ingredients and is commercializing its No Compromise® products in the flavors and fragrances, cosmetics, specialty fluids, polymers, lubricants, and fuels industries. Amyris Brasil Ltda., a subsidiary of Amyris, oversees the establishment and expansion of Amyris's production in Brazil. More information about Amyris is available at www.amyris.com.

Forward-Looking Statements

This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as the development and commercialization of personal care products) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including those associated with any delays or failures in development, production and commercialization of products, the company's ability to launch Biossance The Revitalizer within the timeframe expected, as well as to launch additional Biossance-related products in 2016, the company's ability to effectively manage and operate an e-commerce online sales platform for Biossance, liquidity and ability to fund capital expenditures, the company's reliance on third parties to achieve its goals, and other risks detailed in the "Risk Factors" section of the company's annual report on Form 10-K filed on March 31, 2015. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

Amyris, the Amyris logo, Neossance and Biossance are trademarks or registered trademarks of Amyris, Inc.

CONTACT: Beth Stolrow Vice President, Marketing Amyris, Inc. +1 (510) 450-0761 Peter DeNardo Director, Investor Relations and Corporate Communications Amyris, Inc. +1 (510) 740-7481 investor@amyris.com

Source:Amyris, Inc.